ODONATA INTERNATIONAL LIMITED

Company number 12607093 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

ODONATA INTERNATIONAL LIMITED - Analysis Report

Company Number: 12607093

Analysis Date: 2025-07-29 14:24 UTC

Financial Health Assessment for Odonata International Limited


1. Financial Health Score: D

Explanation:
Odonata International Limited shows significant symptoms of financial distress primarily due to its persistent negative net asset position and substantial long-term liabilities to directors. While current assets exceed current liabilities indicating some short-term liquidity, the overall financial structure is weak, with shareholders' funds deep in the red and a worsening deficit. This positions the company in a vulnerable state, warranting careful monitoring and corrective action.


2. Key Vital Signs

Metric 2024 Value Interpretation
Net Assets (Shareholders’ Funds) £(264,490) Negative net assets indicate the company owes more than it owns; a key symptom of financial distress.
Current Assets £383,800 Healthy level of current assets, including stock and debtors, suggesting some operational activity.
Current Liabilities £1,000 Very low current liabilities; indicates no immediate short-term debt pressure.
Long-Term Liabilities (Directors Loan) £771,818 Significant loan from directors, which may represent deferred funding but is a financial risk.
Cash at Bank £4,985 Low cash reserves, indicating tight day-to-day cash flow despite sizeable current assets.
Stock Level £320,899 High stock level relative to cash; risk of inventory obsolescence or slow turnover.
Trade Debtors £184 Very low trade debtors suggest minimal outstanding customer payments; most current assets are stock.
Profit & Loss Reserve £(264,590) Accumulated losses have eroded equity, indicating sustained historical losses.
Turnover & Profit Data Not disclosed Lack of turnover data limits insight into revenue trends; however, ongoing losses implied by reserves.

3. Diagnosis: What the Financial Data Reveals

  • Chronic Under-Capitalisation: The company’s negative net asset position (over £260k deficit) signals it is technically insolvent on a balance sheet basis. This is akin to a patient with critical internal deficiencies, needing immediate support.

  • Liquidity vs. Solvency Imbalance: While current assets comfortably exceed current liabilities (a positive "working capital" sign), the cash position is very weak. This indicates a "healthy pulse" in short-term operations but poor "organ function" in liquidity management.

  • Heavy Reliance on Director Financing: The large directors’ loan account (£771k) suggests the company depends heavily on insider funding. This is like a patient reliant on external life support, which may not be sustainable long-term without profitability.

  • Inventory Concentration Risk: A large portion of current assets is tied up in stock (£320k), which may pose risks if stock cannot be converted quickly to cash. This represents a "stagnant limb" reducing overall vitality.

  • Limited Trade Debtors: Minimal trade receivables imply sales may be predominantly cash or stock-based, or possibly low sales volume, which could constrain cash inflows.

  • No Audit & Limited Disclosure: The exemption from audit and non-disclosure of profit and loss figures restrict transparency, making it harder to fully assess profitability and cash flow from operations.


4. Recommendations: Specific Actions to Improve Financial Wellness

  1. Improve Capital Structure:
    Consider equity injection or debt restructuring to reduce the negative net asset position. This is akin to replenishing vital reserves and stabilising the patient’s core systems.

  2. Enhance Cash Flow Management:
    Focus on converting stock into cash faster and managing cash reserves prudently to avoid liquidity crises. Implement tighter inventory controls and consider discounts or promotions to accelerate sales.

  3. Review Directors' Loan Terms:
    Formalise and possibly renegotiate directors’ loan terms to ensure they are sustainable and do not threaten solvency if repayment demands arise. Transparent documentation is essential.

  4. Increase Revenue Transparency & Profitability:
    Track turnover and profit margins carefully. Introduce regular management accounts to monitor operational performance and identify early warning signs.

  5. Seek Professional Financial Advice:
    Engage financial advisors to assist with turnaround strategies, including cost control, pricing strategy, and potential refinancing options.

  6. Maintain Compliance & Reporting:
    Continue timely filing of accounts and confirmation statements to preserve corporate standing and stakeholder confidence.


Perspective: Financial Health Diagnostician · Model: gpt-4.1-mini · Generated 29 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.